Sermon Charles has filed 13 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 315750 shares of Mereo BioPharma Group plc ($MREO) on February 01, 2026.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | A | Share Options (Right to buy) | 315750 | $0.00 | 315,750.0000 | 799,947,013 | 9999.99% | 0.04% |
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | A | Share Options (Right to buy) | 295000 | $0.00 | 295,000.0000 | 799,947,013 | 9999.99% | 0.04% |
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | A | Share Options (Right to buy) | 105250 | $0.00 | 105,250.0000 | 799,947,013 | 9999.99% | 0.01% |
| Jan. 25, 2025 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | A | Share Options (Right to buy) | 262000 | $0.00 | 262,000.0000 | 739,624,264 | 9999.99% | 0.04% |
| Sept. 13, 2024 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | S | American Depositary Shares representing Ordinary Shares | 20946 | $4.22 | 219,061.0000 | 770,146,589 | 8.73% | 0.00% |
| Sept. 12, 2024 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | S | American Depositary Shares representing Ordinary Shares | 9980 | $4.47 | 240,007.0000 | 770,146,589 | 3.99% | 0.00% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | M | Performance Based Restricted Stock Unit | 65600 | $0.00 | 0.0000 | 770,146,589 | 100.00% | 0.01% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | M | American Depositary Shares representing Ordinary Shares | 65600 | $0.00 | 249,987.0000 | 770,146,589 | 35.58% | 0.01% |
| June 25, 2024 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | S | American Depositary Shares representing Ordinary Shares | 14202 | $3.69 | 216,574.0000 | 659,453,921 | 6.15% | 0.00% |
| June 26, 2024 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | S | American Depositary Shares representing Ordinary Shares | 32187 | $3.39 | 184,387.0000 | 659,453,921 | 14.86% | 0.00% |
| June 21, 2024 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | M | Performance Based Restricted Stock Unit | 98400 | $0.00 | 65,600.0000 | 659,453,921 | 0.00% | 0.01% |
| June 21, 2024 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | M | American Depositary Shares representing Ordinary Shares | 98400 | $0.00 | 230,776.0000 | 659,453,921 | 74.33% | 0.01% |
| Jan. 25, 2024 | Mereo BioPharma Group plc | $MREO | Sermon Charles | General Counsel | A | Share Options (Right to buy) | 245000 | $0.00 | 245,000.0000 | 659,453,921 | 9999.99% | 0.04% |